Type 2 diabetic patients have increased gluconeogenic efficiency to substrate availability, but intact autoregulation of endogenous glucose production

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 4, 2005, Pages 307-320

  Toft, Ingrid ^a   Jenssen, T ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Autoregulation; Substrate induced glucose production; Type 2 diabetes

Indexed keywords

BICARBONATE; FATTY ACID; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; LACTATE SODIUM; LACTIC ACID;

ADULT; ARTICLE; AUTOREGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE; FATTY ACID BLOOD LEVEL; FEMALE; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GROWTH HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIVER METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATCH CLAMP; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGNAL TRANSDUCTION;

EID: 21344452582     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510510025692     Document Type: Article

References (51)

1. DeFronzo RA. The triumvirate: beta-cells, muscles, liver. A collusion responsible for NIDDM. Diabetes 1988;37:667-87.
2. Tappy L, Acheson K, Curchod B, Schneiter Ph, Normand S, Pachiaudi C, et al. Overnight glucose metabolism in obese non-insulin-dependent diabetic patients and in healthy lean individuals. Clin Physiol 1994;14:251-65.
3. Perriello G, Pampanelli S, Del Sindaco P, Lalli C, Ciofetta M, Volpi E, et al. Evidence of increased systemic glucose production and gluconeogenesis in an early stage of NIDDM. Diabetes 1997;46:1010-6.
4. Consoli A, Nurjhan N, Capani F, Gerich JE. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 1990;38:550-61.
5. Gerich JE. Is muscle the major site of insulin resistance in type 2 (non-insulin-dependent) diabetes mellitus? Diabetologia 1991;34:607-10.
6. Diraison F, Large V, Brunengraber H, Beylot M. Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM. Diabetologia 1998;41:212-20.
7. Jeng CY, Sheu WHH, Fuh MMT, Chen YD, Reaven GM. Relationship between hepatic glucose production and fasting plasma glucose concentration in patients with NIDDM. Diabetes 1994;43:1440-4.
8. Chen YD, Jeng CY, Hollenbeck CB, Wu MS, Reaven GM. Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and in patients with non-insulin-dependent diabetes. J Clin Invest 1988;82:21-5.
9. Beck-Nielsen H, Hother-Nielsen O, Vaag A, Alford F. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of skeletal muscle glucose uptake and hepatic glucose production in the development of hyperglycemia. A critical comment. Diabetologia 1994;37:217-21.
10. Hother-Nielsen O, Beck-Nielsen H. Insulin resistance, but not basal rates of hepatic glucose production in patients with newly diagnosed mild diabetes mellitus. Acta Endocrinol 1991;124:637-45.
11. Boden G, Chen X, Stein P. Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus. Am J Physiol Endocrinol Metab 2001;280:E23-30.
12. Consoli A, Nurjhan N, Reilly JJ, Bier DM, Gerich JE. Mechanism of increased gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 1990;86:2038-45.
13. Magnusson I, Rothman DL, Katz LD, Shulman RG, Shulman GI. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 1992;90:1323-7.
14. Jenssen T, Nurjhan N, Consoli A, Gerich JE. Dose-response effects of lactate infusions on gluconeogenesis from lactate in normal man. Eur J Clin Invest 1993;23:448-54.
15. Randle PJ, Garland PB, Hales CN, Newsholm EA. The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-9.
16. Kreisberg R. Glucose-lactate interrelation in man. N Engl J Med 1972;287:132-7.
17. Yki-Järvinen H, Helve E, Sane T, Nurjahan N, Taskinen MR. Insulin inhibition of overnight glucose production and glucoseneogenesis from lactate in NIDDM. Am J Physiol 1989;256:E732-9.
18. DeFeo PGM, Perriello M, Ventura P, Brunetti F, Santeusanio JJ, Gerich JE, et al. The pancreatic-adrenocortical-pituitary clamp technique for study of counter-regulation in humans. Am J Physiol 1987;252:E565-70.
19. Jenssen T, Nurjahan N, Consoli A, Gerich JE. Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal man: demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest 1990;86:489-97.
20. Toft I, Gerich JE, Jenssen T. Autoregulation of endogenous glucose production during hyperglucagonemia. Metabolism 2002;51:1128-34.
21. Baron A, Schaeffer D, Shragg L, Kolterman OG. Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 1987;36:274-83.
22. McGuire EJ, Halderman J, Tobin R, Andres R, Berman ML. Effects of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 1976;41:565-73.
23. Lowry OH, Passonneau JV. A flexible system of enzymatic analysis. Orlando, Florida: Academic Press Inc., 1972: 200.
24. Kreisberg R, Siegal A, Crawford-Owen D. Glucose-lactate interrelationship effect of ethanol. J Clin Invest 1971;50:175-185.
25. Herbert V, Gottlieb C, Bleicher S. Coated charcoal immunoassay of insulin. J Clin Endocrinol 1965;25:1375-84.
26. Faber OK, Binder C. C-peptide response to glucagon: a test for the residual beta-cell function in diabetes mellitus. Diabetes 1977;26:605-10.
27. Faloona G, Unger R. Glucagon. In Jaffe B, Behrman H, editors. Methods of hormone radioimmunoassay. New York, NY: Academic Press, 1974: 317-30.
28. Peake G. Growth hormone. In Jaffe B, Behrman H, editors. Methods of hormone radioimmunoassay. New York, NY: Academic Press, 1974: 103-21.
29. DeBodo RR, Steele N, Altszuler A, Dunn D, Bishop J. On the hormonal regulation of carbohydrate metabolism: studies with 14C glucose. Recent Prog Horm Res 1963;19:445-8.
30. Searle G, Cavalieu R. Determination of lactate kinetics in human analysis of data from single injection vs continuous infusion methods. Proc Soc Exp Biol Med 1972;139:1002-6.
31. Chiasson J, Liljenquist JW, Lacy A, Jennings B, Cherrington A. Gluconeogenesis: methodological approaches in vivo. Fed Proc 1977;36:229-35.
32. Mevorach M, Giacca A, Aharon Y, Hawkins M, Shamoon H, Rosetti L. Regulation of endogenous glucose production by glucose per se is impaired in type 2 diabetes mellitus. J Clin Invest 1998;102:744-53.
33. Consoli A, Kennedy F, Miles J, Gerich JE. Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man. J Clin Invest 1987;80:1303-10.
34. 14C-labelled substrates. Am J Physiol 1986;248:R391-9.
35. Hetenyi G Jr. Correction for the metabolic exchange of 14C for 12C in the pathway of gluconeogenesis in vivo. Federation Proc 1985;41:104-9.
36. Groop LC, Saloranta C, Shank M, Bonnadonna RC, Ferrannini E, DeFronzo RA. The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1991;72:96-107.
37. DeFronzo RA, Simonson D, Ferrannini E. Hepatic and peripheral insulin resistance: a common feature of type 2 (non-insulin-dependent) and type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1982;23:313-8.
38. Bogardius C, Lillioja S, Howard B, Reaven G, Mott D. Relationship between insulin secretion, insulin action, and fasting plasma glucose concentration in non-diabetic and non-insulin-dependent diabetic subjects. J Clin Invest 1984;74:1238-46.
39. Paquot N, Schneiter Ph, Jèquier E, Gaillard R, Lefèbvre PJ, Scheen A, Tappy L. Effects of ingested fructose and infused glucagon on endogenous glucose production in obese NIDDM patients, obese non-diabetic subjects, and healthy subjects. Diabetologia 1996;39:580-6.
40. Puhakainen I, Koivisto VA, Yki-Järvinen H. No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 1991;40:1319-27.
41. Puhakainen I, Yki-Järvinen H. Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate, but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 1993;42:1694-1699.
42. 13C]glucose study. Am J Physiol 1996;270:E709-17.
43. Clore JN, Stillman J, Sugerman H. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 2000;49:969-74.
44. Magnusson I, Rothman DL, Jucker B, Cline GW, Shulman RG, Shulman GI. Liver glycogen turnover in fed and fasted humans. Am J Physiol 1994;266:E796-803.
45. McGuinness OP, Ejiofor J, Audoly LP, Schrom N. Regulation of glucose production by NEFA and gluconeogenic precursors during chronic glucagons infusion. Am J Physiol 1998;275:E432-9.
46. Foster DW. The role of the carnitine system in human metabolism. Ann NY Acad Sci 2004;1033:1-16.
47. Seppälà-Lindroos A, Vehkavaara S, Hãkkinin AM, Goto T, Westerbacka J, Sovijãrvi A, Halavaara J, Yki-Jàrvinen H. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metabol 2002;87:3023-8.
48. Unger RH. Lipid overload and overflow: metabolic trauma and the metabolic syndrome. Trends Endocrinol Metab 2003;14:398-403.
49. Magnusson I, Rothman DL, Gerard DP, Katz LD, Shulman GI. Contribution of hepatic glycogenolysis to glucose production in response to a physiological increase in plasma glucagons. Diabetes 1995;44:185-9.
50. Gerich JE. Hormonal and substrate determinants of hepatic glucose production in man. In Veneziale CM, editor. The regulation of carbohydrate formation and utilization in mammals. Baltimore: BA, University Park Press, 1981: 419-57.
51. Miyoshi H, Shulman GI, Peters EJ, Wolfe MH, Elahi D, Wolfe RR. Hormonal control of substrate cycling in humans. J Clin Invest 1988;81:1545-55.